Gang Wang

Title: **Innovative Contributions of Inventor Gang Wang**

Introduction

Gang Wang, an accomplished inventor based in Piscataway, NJ, has made significant strides in the field of oligonucleotide synthesis and purification. With three patents to his name, his latest work showcases groundbreaking advancements that enhance the efficiency and effectiveness of DNA and RNA synthesis.

Latest Patents

Gang Wang's most recent patents focus on the "Process for desilylation of oligonucleotides." This innovative invention pertains to processes and reagents tailored for oligonucleotide synthesis and purification. Key aspects include:

- The development of compounds that activate phosphoramidites during oligonucleotide synthesis.

- A method for preparing oligonucleotides using the phosphoramidite method, enhanced with specialized activators.

- The introduction of sulfur-transfer agents, particularly 3-amino-1,2,4-dithiazolidine-5-one, which facilitate the preparation of phosphorothioates by treating phosphites with this reagent.

- The incorporation of acrylonitrile scavengers, specifically polymer-bound thiols, to mitigate byproduct formation during the deprotection of certain phosphate groups.

- Agents designed to oxidize phosphites into phosphates, utilizing common oxidizing agents like sodium chlorite, chloroamine, or pyridine-N-oxide.

- A novel method for purifying oligonucleotides by annealing single-stranded oligonucleotides to form double-stranded structures, followed by high-performance liquid chromatography for purification.

Career Highlights

Gang Wang is associated with Alnylam Pharmaceuticals, Inc., a company recognized for its pioneering work in RNAi therapeutics. His innovative approaches and contributions to oligonucleotide chemistry continue to enhance the research capabilities in biotechnology and pharmaceutical development.

Collaborations

Throughout his career, Gang Wang has collaborated with esteemed colleagues such as Muthiah Manoharan and Kallanthottathil G Rajeev. These partnerships have bolstered research efforts and enhanced the outcomes of various projects focused on nucleic acid therapies.

Conclusion

Gang Wang's contributions to the field of oligonucleotide synthesis and purification have highlighted his innovative spirit and dedication to advancing biotechnological research. His patents not only reflect his expertise but also showcase the potential for significant advancements in therapeutic development. As he continues his work at Alnylam Pharmaceuticals, Wang remains a vital figure in the landscape of pharmaceutical innovation.